文献速递呼吸道感染间质性肺疾病

单核细胞迁移特征定义急性COVID-19疾病严重程度及长新冠独特特征

Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID.
PubMed 文献 · Eur Respir J · 2023-05-11

研究评估COVID-19患者住院期间及康复期长达9个月的单核细胞表型与功能变化,并与呼吸道合胞病毒或甲型流感康复者及进行性纤维化间质性肺病患者对照。发现急性COVID-19单核细胞迁移分子表达异常并持续至康复期,长新冠伴持续肺损伤者以单核细胞CXCR6和PSGL-1高表达及向CXCL16迁移为特征,而伴疲劳者COX-2和CXCR2持续降低,这些变化不见于其他呼吸道病毒康复者。

要点

  • 长新冠伴持续肺损伤者单核细胞CXCR6高表达并向肺高表达的CXCL16迁移。
  • 长新冠伴疲劳者单核细胞COX-2和CXCR2表达持续降低。
  • 上述单核细胞变化在呼吸道合胞病毒或甲型流感康复者中未出现。

核心结论

  • 单核细胞迁移特征可定义长新冠患者亚组,提示单核细胞迁移在COVID-19病理生理中起关键作用。

研究设计与样本

  • 评估COVID-19患者住院期间及康复期长达9个月的单核细胞表型与功能变化,并与呼吸道合胞病毒或甲型流感康复者对照,以进行性纤维化间质性肺病患者作为阳性对照。

主要发现

  • 急性COVID-19单核细胞迁移分子表达异常,持续至康复期(n=142)并与长新冠特定症状对应。
  • 长新冠伴持续气短和胸部影像异常者单核细胞CXCR6高表达(p<0.0001)、PSGL-1高表达(p<0.01),且向CXCL16迁移增强(p<0.05)。
  • 进行性纤维化间质性肺病患者单核细胞CXCR6和肺CXCL16升高(p<0.001)。
  • 长新冠伴持续疲劳者单核细胞COX-2(p<0.01)和CXCR2(p<0.05)表达持续降低。
  • 上述单核细胞变化未见于呼吸道合胞病毒或甲型流感康复者。

临床怎么用

  • 单核细胞CXCR6-CXCL16轴和COX-2/CXCR2通路可能为长新冠持续病症提供新的治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COVID-19 is associated with a dysregulated immune response but it is unclear how immune dysfunction contributes to the chronic morbidity persisting in many COVID-19 patients during convalescence (long COVID). METHODS: We assessed phenotypical and functional changes of monocytes in COVID-19 patients during hospitalisation and up to 9 months of convalescence following COVID-19, respiratory syncytial virus or influenza A. Patients with progressive fibrosing interstitial lung disease were included as a positive control for severe, ongoing lung injury. RESULTS: Monocyte alterations in acute COVID-19 patients included aberrant expression of leukocyte migration molecules, continuing into convalescence (n=142) and corresponding with specific symptoms of long COVID. Long COVID patients with unresolved lung injury, indicated by sustained shortness of breath and abnormal chest radiology, were defined by high monocyte expression of C-X-C motif chemokine receptor 6 (CXCR6) (p<0.0001) and adhesion molecule P-selectin glycoprotein ligand 1 (p<0.01), alongside preferential migration of monocytes towards the CXCR6 ligand C-X-C motif chemokine ligand 16 (CXCL16) (p<0.05), which is abundantly expressed in the lung. Monocyte CXCR6 and lung CXCL16 were heightened in patients with progressive fibrosing interstitial lung disease (p<0.001), confirming a role for the CXCR6-CXCL16 axis in ongoing lung injury. Conversely, monocytes from long COVID patients with ongoing fatigue exhibited a sustained reduction of the prostaglandin-generating enzyme cyclooxygenase 2 (p<0.01) and CXCR2 expression (p<0.05). These monocyte changes were not present in respiratory syncytial virus or influenza A convalescence. CONCLUSIONS: Our data define unique monocyte signatures that define subgroups of long COVID patients, indicating a key role for monocyte migration in COVID-19 pathophysiology. Targeting these pathways may provide novel therapeutic opportunities in COVID-19 patients with persistent morbidity.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Scott NA, Pearmain L, Knight SB, et al. Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID. Eur Respir J. 2023. PMID: 36922030. doi:10.1183/13993003.02226-2022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。